Draft recommendations: The Working Group was tasked to address the following overall policy questions:
1. Should TCV be recommended in addition to the available ViPS and Ty21a vaccines for routine use in persons 2 years of age and older?a (Critical questionb)
2. Should TCV be recommended for routine use in children less than 2 years of age? What should be the lower age limit for use in this group? (Critical question)
3. Should different recommendations be developed for use of the above vaccines in endemic settings versus outbreaks or humanitarian emergencies? (Non-critical question)

  • SAGE background document
  • Typhoid